GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SKAN Group AG (XSWX:SKAN) » Definitions » Debt-to-EBITDA

SKAN Group AG (XSWX:SKAN) Debt-to-EBITDA : 0.13 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SKAN Group AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

SKAN Group AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF0.9 Mil. SKAN Group AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF5.6 Mil. SKAN Group AG's annualized EBITDA for the quarter that ended in Dec. 2023 was CHF48.6 Mil. SKAN Group AG's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.13.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for SKAN Group AG's Debt-to-EBITDA or its related term are showing as below:

XSWX:SKAN' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.14   Med: 0.46   Max: 0.47
Current: 0.14

During the past 4 years, the highest Debt-to-EBITDA Ratio of SKAN Group AG was 0.47. The lowest was 0.14. And the median was 0.46.

XSWX:SKAN's Debt-to-EBITDA is ranked better than
83.02% of 430 companies
in the Medical Devices & Instruments industry
Industry Median: 1.245 vs XSWX:SKAN: 0.14

SKAN Group AG Debt-to-EBITDA Historical Data

The historical data trend for SKAN Group AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SKAN Group AG Debt-to-EBITDA Chart

SKAN Group AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
- 0.47 0.46 0.14

SKAN Group AG Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial 0.51 - 0.34 - 0.13

Competitive Comparison of SKAN Group AG's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, SKAN Group AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SKAN Group AG's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SKAN Group AG's Debt-to-EBITDA falls into.



SKAN Group AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

SKAN Group AG's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.871 + 5.619) / 45.545
=0.14

SKAN Group AG's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.871 + 5.619) / 48.614
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


SKAN Group AG  (XSWX:SKAN) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


SKAN Group AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SKAN Group AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


SKAN Group AG (XSWX:SKAN) Business Description

Traded in Other Exchanges
Address
Kreuzstrasse 5, Allschwil, CHE, 4123
SKAN Group AG is a global market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offer its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbench, and transfer system.

SKAN Group AG (XSWX:SKAN) Headlines

No Headlines